[SRNE] YoY Annual Result on 31-Dec-2014 [#FY]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
13-Mar-2015
Financial Year
2014
Quarter
31-Dec-2014 [#FY]
Profit Trend
YoY- -58.17%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Annual Result
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Revenue 151,856 8,152 4,590 3,825 460 584 529 156.61%
PBT 15,315 -64,833 -13,760 -36,359 -21,911 -4,845 -3,236 -
Tax -36,038 -896 36,314 -1,702 10 15 12 -
NP 9,061 -60,923 -45,811 -34,657 -21,911 -4,845 -3,236 -
Tax Rate 235.31% - - - - - - -
Total Cost 142,795 69,075 50,401 38,482 22,371 5,429 3,766 83.18%
Ratio Analysis
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
NP Margin 5.97 -747.34 -998.06 -906.07 -4,761.79 -830.00 -611.60 -
Per Share
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
EPS 0.13 -1.21 -1.24 -1.30 -1.46 -0.42 -0.33 -
EPS Diluted 0.13 -1.21 -1.24 -1.30 -1.46 -0.42 -0.33 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.